Literature DB >> 2777955

An improved method for the separation and quantification of glutathione S-transferase subunits in rat tissue using high-performance liquid chromatography.

J J Bogaards1, B van Ommen, P J van Bladeren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2777955     DOI： 10.1016/s0021-9673(01)93940-8

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  6 in total

1.  Quantification of human hepatic glutathione S-transferases.

Authors:  B van Ommen; J J Bogaards; W H Peters; B Blaauboer; P J van Bladeren
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

2.  Irreversible inhibition of rat glutathione S-transferase 1-1 by quinones and their glutathione conjugates. Structure-activity relationship and mechanism.

Authors:  B van Ommen; J H Ploemen; J J Bogaards; T J Monks; S S Gau; P J van Bladeren
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

3.  Structure-activity relationships for chemical and glutathione S-transferase-catalysed glutathione conjugation reactions of a series of 2-substituted 1-chloro-4-nitrobenzenes.

Authors:  E M Van der Aar; T Bouwman; J N Commandeur; N P Vermeulen
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

4.  Glutathione analogues as novel inhibitors of rat and human glutathione S-transferase isoenzymes, as well as of glutathione conjugation in isolated rat hepatocytes and in the rat in vivo.

Authors:  S Ouwerkerk-Mahadevan; J H van Boom; M C Dreef-Tromp; J H Ploemen; D J Meyer; G J Mulder
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

5.  Purification and characterization of eight glutathione S-transferase isoenzymes of hamster. Comparison of subunit composition of enzymes from liver, kidney, testis, pancreas and trachea.

Authors:  J J Bogaards; B van Ommen; P J van Bladeren
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

6.  Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.

Authors:  A G van der Zee; B van Ommen; C Meijer; H Hollema; P J van Bladeren; E G de Vries
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.